Riskpilot← Back to searchSign inGet full accessVitabalans Oy
OYActiveY-tunnus 0398964-3Varastokatu 8Manufacture of pharmaceutical preparations · NACE 2120Est. 1980175 employeeswww.vitabalans.fi
Revenue 2025
EUR 47,6M
+3% vs 2024
EBITDA margin
24.2%
-9% vs 2024
Equity ratio
90.5%
Financial strength
Net profit 2025
EUR 7,8M
-14% vs 2024
| Revenue | EUR 47,6M | +3% |
| EBITDA | EUR 11,5M | -9% |
| Net profit | EUR 7,8M | -14% |
| Total assets | EUR 61,7M | +13% |
| Equity | EUR 55,8M | +13% |
| Employees | 175 | — |
Legal name
Vitabalans Oy
Y-tunnus number
0398964-3
Legal form
Osakeyhtiö
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
14. marraskuuta 1980
Share capital
EUR 43 056
Employees
175 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimiala erityiselintarvikkeiden, teknokemiallisten ja farmaseuttisten tuotteiden valmistus, maahantuonti ja kauppa, sekä arvopapereiden, kiinteistöjen, koneiden ja laitteiden ostaminen, hallitseminen ja myyminen sekä kiinteistöjen rakentaminen ja urakointi.
Address
Varastokatu 8
Phone
+35803615600
Website
www.vitabalans.fi
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | 30 047 | 34 144 | 36 043 | 39 281 | 44 695 | 46 367 | 47 614 |
| Staff expenses | −7 231 | −7 527 | −8 103 | −8 869 | −11 847 | −12 522 | −12 958 |
| EBITDA | 4 542 | 6 910 | 7 439 | 8 628 | 14 233 | 12 699 | 11 513 |
| Depreciation & amort. | −984 | −1 128 | −1 139 | −1 194 | −1 317 | −1 373 | −1 661 |
| EBIT | 3 558 | 5 782 | 6 300 | 7 434 | 12 916 | 11 326 | 9 852 |
| Net financials | 226 | 183 | 552 | 353 | −34 | 52 | −56 |
| Profit before tax | 3 121 | 5 702 | 6 283 | 7 795 | 12 882 | 11 378 | 9 796 |
| Tax | 577 | 1 102 | 1 146 | 1 461 | 1 972 | 2 321 | 1 964 |
| Net profit | 2 544 | 4 600 | 5 137 | 6 318 | 10 910 | 9 058 | 7 832 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Total assets | 24 690 | 28 435 | 32 778 | 37 447 | 48 325 | 54 559 | 61 684 |
| Equity | 20 875 | 24 276 | 28 282 | 31 254 | 42 082 | 49 566 | 55 818 |
| Long-term debt | 315 | 587 | 642 | — | 0 | 0 | 0 |
| Short-term debt | 3 501 | 3 574 | 3 856 | 3 986 | 6 242 | 4 994 | 5 866 |
| Total debt | 3 816 | 4 161 | 4 498 | 3 986 | 6 242 | 4 994 | 5 866 |
EBITDA margin
24.2%
This company
15.8%
Market median
+53% vs market
20192025
Equity ratio
90.5%
This company
38.2%
Market median
+137% vs market
20192025
Return on equity
14.0%
This company
18.4%
Market median
+24% vs market
20192025
Net profit margin
16.4%
This company
8.1%
Market median
+102% vs market
20192025
Asset turnover
0.77×
This company
1.12×
Market median
-31% vs market
20192025
Debt / equity
0.11×
This company
0.62×
Market median
+82% vs market
20192025
- Annual report 2025Filed via PRH / YTJ · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via PRH / YTJ · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via PRH / YTJ · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via PRH / YTJ · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via PRH / YTJ · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via PRH / YTJ · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via PRH / YTJ · Period 2018-07-01 – 2019-06-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AR Deputy auditor | Deputy auditor | 2025 | — | — |
JA | Audit | 2011 | — | — |
MV | Audit | 2019 | — | — |
JP Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
SM Deputy auditor | Deputy auditor | 2011 | — | — |
MK | Audit | 2025 | — | — |
JH Chief Executive Officer | Chief Executive Officer | 2026 | — | — |
MJ Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
MP | Audit | 2019 | — | — |
JH Audit | Audit | 2023 | — | — |
JK Deputy auditor | Deputy auditor | 2019 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairperson | 2012 | — | — | |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2012 | — | — | |
| Board of Directors | 2012 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Riihimäen Terveysmajakka Oy | Company | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Riihimäen Terveysmajakka Oy
Vitabalans Oy (this company)Vitabalans As, NorjaVitabalans SP z.o.o.Birger Ledin AB, RuotsiSIA VitabalansVitabalans Cz s.r.o.Vitabalans SK s.r.o.Vitabalans Kft, UnkariBlanco Pharma GmbH, SaksaVitabalans KftVitabalans ApSVitabalans Pharma OüVitabalans AB, RuotsiVitabalans d.o.o., SloveniaUAB VitabalansBoard members of Vitabalans Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anna-Mari Riihimäki | Deputy auditor | 0 companies |
| Jari Anttoni Miikkulainen | Audit | 0 companies |
| Matias Valtteri Leino | Audit | 0 companies |
| Janne Petteri Strömberg | Chief Executive Officer | 0 companies |
| Suvi Maria Suonsivu | Deputy auditor | 0 companies |
| Markku Kalervo Launis | Audit | 0 companies |
| Juho Henrik Taipale | Chief Executive Officer | 0 companies |
| Mervi Johanna Salmela | Chief Executive Officer | 0 companies |
| Mika Petteri Järvinen | Audit | 0 companies |
| Juho Heikki Leinonen | Audit | 0 companies |
| Janne Kari Ilari Elo | Deputy auditor | 0 companies |
| Jorma Anssi Väinämöinen Taipale | Chairperson | 0 companies |
| Krista Katariina Taipale-Kovalainen | Board of Directors | 0 companies |
| Irmeli Marja-Liisa Taipale | Board of Directors | 0 companies |
| Jussi Tapio Kokkila | Board of Directors | 0 companies |